- Ages
- 30 Years - NA Years
- Sexes
- All
Clinical trials
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial -
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All
-
Hypothyroidism: Efficacy and Safety of Armour Thyroid Treatment in Subjects with Primary Hypothyroidism - Investigators
- Joe M Chehade, Christian A Koch, Payal Shooliz
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
Ambition - Investigator
- Steven E Morales-Rivera
- Ages
- 18 Years - N/A
- Sexes
- All
-
VANTAGE study - Investigator
- Neha Agrawal
- Ages
- 18 Years - NA Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All